Tamoximed 20 mg Balkan Pharmaceuticals
€0.00
Description
Discover Tamoximed 20 mg Balkan Pharmaceuticals: Your Essential Estrogen Blocker
Tamoximed 20 mg Balkan Pharmaceuticals is a powerful aromatase inhibitor designed to support individuals looking to manage estrogen levels effectively. This selective estrogen receptor modulator (SERM) primarily functions by blocking estrogen receptors in the body, making it an ideal choice for those facing challenges such as gynecomastia, especially when using anabolic steroids. With its capability to reduce the effects of estrogen, Tamoximed is essential for both therapeutic and sports-related applications.
Key Advantages of This Effective Aromatase Inhibitor
When considering a product for managing estrogen levels, it’s crucial to understand its benefits thoroughly. Tamoximed offers a variety of advantages that make it a preferred choice among users. Here are some of the key benefits:
- Effective in reducing estrogen-related side effects
- Promotes hormonal balance, especially during steroid cycles
- Low risk of hepatotoxicity allows for safer long-term use
- Convenient blister packaging for easy dosage management
These benefits highlight the importance of Tamoximed in both medical and sports settings, ensuring users can maintain optimal health while mitigating the consequences of increased estrogen levels.
Long-Term Effects and Practical Applications of Tamoximed 20 mg Balkan Pharmaceuticals
Tamoximed 20 mg Balkan Pharmaceuticals not only serves its purpose in the short term but also provides long-lasting effects that contribute to hormonal wellbeing. Users of Tamoximed can expect a stabilisation in their hormonal balance over time, which can be vital for those undergoing hormone replacement therapy or steroid cycles. Regular use may prevent complications associated with high estrogen levels, particularly in male athletes.
Monitoring liver function is recommended, although cases of severe complications are rare. The ease of use, along with minimal side effects, positions Tamoximed as a reliable choice for those looking to counteract unwanted estrogenic effects. For many, maintaining an optimal hormonal environment is essential for performance and overall health, making Tamoximed a cornerstone product in their regimen.
Additional information
| Active substance | Tamoxifene |
|---|---|
| Release form | Blister (15 Pills), Pack (105 pills) |
| Water Retention | No |
| Hepatotoxicity | Low, but rare cases of liver cancer and liver-related deaths have been reported |
| Lab Test | Monitoring liver function tests is recommended |
| Also known as | TAM, tamoxifen citrate |
| Blood pressure | Little to no effect on blood pressure |
| Trade name | Nolvadex, Soltamox |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine |
| Formula | C26H29NO |
| Substance class | Selective Estrogen Receptor Modulator (SERM) |
| Main action | Estrogen receptor antagonist |
| Half-life | 5 to 7 days |
| Dosage (medical) | 20 mg daily |
| Dosage (sports) | 10-20 mg daily |
| Effects | Reduces the effect of estrogen in the body, can stimulate ovulation |
| Side effects | Hot flashes, vaginal discharge, menstrual irregularities, increased risk of endometrial cancer, cataracts, and thromboembolic events such as deep vein thrombosis and pulmonary embolism |
| Use in sports | Used to counteract the side effects of anabolic steroids, specifically gynecomastia |
| Active ingredient, mg | 20 |
| 1 Pill, mg | 20 |
| Blister, pills | 2, 15 |
| Manufacturer | Balkan Pharmaceuticals |
| Packing | Blister (15 Pills), Packing (2 blisters) |
Related products
-

Tamoximed 10 mg Balkan Pharmaceuticals
€19.00 Select options This product has multiple variants. The options may be chosen on the product page -

Exos 25 mg Pharmacom Labs
€64.00 Select options This product has multiple variants. The options may be chosen on the product page -

Proviron 50 mg Magnus Pharmaceuticals
€47.00 Add to basket

Reviews
There are no reviews yet.